NIH consensus development statement on hydroxyurea treatment for sickle cell disease.
Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi CE, James AH, Laraque D, Mendez MH, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M.
Brawley OW, et al. Among authors: mendez mh.
NIH Consens State Sci Statements. 2008 Feb 27-29;25(1):1-30.
NIH Consens State Sci Statements. 2008.
PMID: 18309362